Released yesterday by the Department of Defense (DOD) Special Assistant for Gulf War Illnesses and the RAND Corporation, a 385-page report concluded that the drug Pyridostigmine Bromide, or "PB," could not be ruled out as a possible cause for some of the illnesses veterans of the Gulf War have reported. The Office of the Special Assistant for Gulf War Illnesses site contains a message from the Special Assistant regarding this report, previous RAND reports on other suspected sources of Gulf War Illness, and a number of other related resources.
Comments